Regeneron Reports First Quarter 2017 Financial and Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. USO
2. MRVL
3. SPY
4. BBIO
5. NVDA
6. GOOGL
7. OPCH
8. CHRW
9. AMD
10. HUBS

Go back to Regeneron Reports First Quarter 2017 Financial and Operating Results

Regeneron Pharma (REGN) PT Raised to $475 at Cowen

May 4, 2017 3:39 PM EDT

Cowen raised its price target on Regeneron Pharma (NASDAQ: REGN) to $475.00 (from $380.00) while maintaining a Market Perform rating following Q1 results.

Analyst Phil Nadeau is updating estimates to reflect Dupixent's fast start, Eylea's deceleration.

FY 2017 EPS goes from $12.25 to $1.25 and FY 2018 EPS goes from $14.90 to $13.20.

... More

Regeneron (REGN) Misses Q1 EPS by 15c, Offers FY Guidance

May 4, 2017 6:40 AM EDT

Regeneron (NASDAQ: REGN) reported Q1 EPS of $2.92, $0.15 worse than the analyst estimate of $3.07. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.3... More